|
| | COMT genotype | |
| Full sample | Val/Val | Val/Met | Met/Met | |
| ( 192) | ( 54) | ( 103) | ( 35) | |
|
Age (years) M (sd) | 37 (9) | 35 (9) | 38 (9) | 39 (11) | |
Education (years) M (sd) | 13 (2) | 13 (2) | 13 (2) | 14 (2) | |
WRAT4 M (sd) | 100 (12) | 99 (11) | 100 (12) | 104 (11) | |
Ethnicity (row ) | | | | | |
Caucasian | 71 | 52 | 78 | 83 | v/v v/m, m/m** |
African-American | 15 | 32 | 7 | 11 | v/v v/m, m/m** |
Hispanic | 14 | 17 | 16 | 6 | |
Executive Functioning Battery | | | | | |
Wisconsin card sort test T (sd) | 45 (14) | 47 (16) | 44 (13) | 46 (13) | |
Trials part B T (sd) | 49 (11) | 51 (12) | 47 (10) | 52 (11) | |
Halstead category Test T (sd) | 46 (10) | 47 (10) | 44 (10) | 47 (9) | |
Domain deficit score M (sd) | .55 (.69) | .56 (.68) | .62 (.74) | .35 (.47) | |
Executive impairment () | 45 | 46 | 50 | 31 | |
Sexual Characteristics/Behavior | | | | | |
Age at first intercourse (sd) | 15 (4) | 14 (4) | 16 (4) | 17 (4) | v/v m/m* |
Sexual preference (% heterosexual) | 33 | 35 | 31 | 38 | |
Number partners in past 12 mo Median (IQR) | 3 (1,10) | 4 (1, 11) | 3 (1, 10) | 2 (1, 5) | |
Condom use (0% in past 12 mo) | 72 | 74 | 71 | 70 | |
Insertive anal (0% in past 12 mo) | 62 | 60 | 67 | 52 | |
Receptive anal (0% in past 12 mo) | 58 | 60 | 62 | 46 | |
Oral sex (0% in past 12 mo) | 93 | 94 | 93 | 94 | |
Intoxicated sex (0% in past 12 mo) | 64 | 63 | 66 | 61 | |
Vaginal sex (0% in past 12 mo) | 37 | 35 | 35 | 44 | |
DSM-IV Psychiatric Disorder ( lifetime) | | | | | |
Major depression | 36 | 36 | 35 | 40 | |
Bipolar I or II | 4 | 8 | 3 | 3 | |
Beck depression inventory M (sd) | 12 (9) | 11 (8) | 13 (10) | 10 (9) | |
DSM-IV Substance Dependence ( lifetime) | | | | | |
Sedative | 0 | 0 | 0 | 0 | |
Cannabis | 9 | 9 | 11 | 6 | |
Opioid | 0 | 0 | 0 | 0 | |
Cocaine | 7 | 7 | 5 | 14 | |
Hallucinogen | 0 | 0 | 0 | 0 | |
Alcohol | 17 | 15 | 20 | 14 | |
Methamphetamine Parameters | | | | | |
Methamphetamine dependent () | 47 | 37 | 52 | 49 | |
Age at first METH use, yrs M (sd) | 24 (9) | 23 (9) | 25 (8) | 27 (10) | |
Total METH use, yrs M (sd) | 11 (6) | 13 (7) | 11 (6) | 8 (4) | v/v m/m* |
Last use of METH, days Median (IQR) | 91 (36, 274) | 122 (45, 731) | 91 (32, 236) | 91 (30, 244) | |
HIV Parameters | | | | | |
HIV seropositive () | 56 | 70 | 51 | 49 | v/v v/m, m/m* |
HIV RNA, plasma (log copies/mL) M (sd) | 2.1 (1.9) | 2.4 (1.7) | 2.0 (2.0) | 1.7 (1.9) | |
|